2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Multiple Organ Dysfunction Syndrome: new trials by email Literature Review of Multiple Organ Dysfunction Syndrome trials Research Report on Multiple Organ Dysfunction Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Eculizumab to Treat Thrombotic Microangiopathy/Atypical Hemolytic Uremic Syndrome -Associated Multiple Organ Dysfunction Syndrome in Hematopoietic Stem Cell Transplant Recipients Eculizumab - Thrombotic Microangiopathies, Atypical Hemolytic Uremic Syndrome | Phase 2 | Completed | Children's Hospital Medical Center, Cincinnati | 23 | 2018-08-03 | 2023-09-21 |
| Bovine Intestinal Alkaline Phosphatase for the Treatment of Patients With Sepsis Alkaline Phosphatase, Placebo - Sepsis, Multiple Organ Dysfunction Syndrome | Phase 2 | Completed | AM-Pharma | 37 | 2004-09-01 | 2012-04-02 |
Multiple Organ Failure (2) · Atypical Hemolytic Uremic Syndrome (1) · Sepsis (1) · Thrombotic Microangiopathies (1)
Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Shock (2) · Anemia (1) · Anemia, Hemolytic (1) · Blood Platelet Disorders (1) · Cytopenia (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemolytic-Uremic Syndrome (1) · Infections (1) · Inflammation (1) · Kidney Diseases (1)
2-(3',4'-dihydroxyphenyl-1-azo)benzimidazole (1) · Alkaline Phosphatase (1) · Sodium Chloride (1) · eculizumab (1)
AM-Pharma (1) · Children's Hospital Medical Center, Cincinnati (1)
Belgium (1) · Netherlands (1) · United States (1)
Bart Wuurman, M.Sc. (1) · Sonata Jodele, MD (1)